Lyrette: Renewing Continence Objective and Subjective Efficacy Study

NAUnknownINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Stress Urinary Incontinence
Interventions
DEVICE

Lyrette

"The Verathon Transurethral RF System (Lyrette® System) is indicated for the treatment of female urinary stress incontinence (SUI) due to hypermobility in women who have failed conservative treatment and who are not candidates for surgical therapy.~The treatment is a 9 minute non-surgical procedure completed using local anesthesia during a single office visit. Women are discharged home with no incisions, dressings, or catheters immediately following treatment."

Trial Locations (6)

23507

Eastern Virginia Medical School, Norfolk

37203

Dial Research, Tennessee Women's Care, Nashville

49503

Female Pelvic Medicine and Urogynecology, Grand Rapids

60004

Center for Bladder Control, Arlington Heights

60453

Women's Health Institute of Illinois, Oak Lawn

92562

Tri Valley Urology Medical Group, Murrieta

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Verathon

INDUSTRY

NCT01455779 - Lyrette: Renewing Continence Objective and Subjective Efficacy Study | Biotech Hunter | Biotech Hunter